Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

OABI

OmniAb Inc

Mar 28 • 04:00PM ET

2.42

Dollar change -0.05
Percentage change -2.02	%

Healthcare • Biotechnology • USA • NASD

Peers: REGN VRTX ONC EBS FOLD KURA MGNX ADAP XBIT ONCT

| Held by: VTI IWM VXF IWN VTWO SCHA DFAT VHT DFAS IWC

Index	RUT	P/E	-	EPS (ttm)	-0.61	Insider Own	19.16%	Shs Outstand	121.60M	Perf Week	-4.35%
Market Cap	295.57M	Forward P/E	-	EPS next Y	-0.49	Insider Trans	-0.23%	Shs Float	97.83M	Perf Month	-30.86%
Income	-62.03M	PEG	-	EPS next Q	-0.16	Inst Own	53.64%	Short Float	7.64%	Perf Quarter	-31.44%
Sales	26.39M	P/S	11.20	EPS this Y	2.05%	Inst Trans	-0.48%	Short Ratio	12.01	Perf Half Y	-42.24%
Book/sh	2.37	P/B	1.02	EPS next Y	18.27%	ROA	-16.31%	Short Interest	7.48M	Perf Year	-53.37%
Cash/sh	0.49	P/C	4.97	EPS next 5Y	18.93%	ROE	-20.60%	52W Range	2.23 - 5.54	Perf YTD	-31.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-20.21%	52W High	-56.34%	Beta	0.04
Dividend TTM	-	Quick Ratio	4.52	Sales past 5Y	1.70%	Gross Margin	20.87%	52W Low	8.48%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	4.52	EPS Y/Y TTM	-19.65%	Oper. Margin	-281.19%	RSI (14)	30.90	Volatility	4.04% 6.09%
Employees	114	Debt/Eq	0.08	Sales Y/Y TTM	-22.75%	Profit Margin	-235.05%	Recom	1.00	Target Price	8.50
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	11.12%	Payout	-	Rel Volume	1.43	Prev Close	2.47
Sales Surprise	6.69%	EPS Surprise	-18.46%	Sales Q/Q	124.06%	Earnings	Mar 18 AMC	Avg Volume	622.63K	Price	2.42
SMA20	-18.10%	SMA50	-25.59%	SMA200	-37.70%	Trades		Volume	889,253	Change	-2.02%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-23	Initiated	RBC Capital Mkts	Outperform	$6
Apr-21-23	Initiated	The Benchmark Company	Buy	$8
Apr-13-23	Initiated	Craig Hallum	Buy	$10
Feb-22-23	Initiated	Cowen	Outperform	$10
Feb-13-23	Initiated	H.C. Wainwright	Buy	$11
Dec-20-22	Initiated	Truist	Buy	$10
Dec-16-22	Initiated	Credit Suisse	Outperform	$13
Nov-29-22	Initiated	SVB Leerink	Outperform	$6
Nov-28-22	Initiated	Stifel	Buy	$12

Mar-18-25 04:05PM	OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights (Business Wire) -20.38%
Feb-24-25 08:00AM	OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 (Business Wire)
Feb-03-25 04:57PM	OmniAb to Participate in Two Investor Conferences in March (Business Wire)
Dec-16-24 04:15PM	OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering and Therapeutics Conference (Business Wire)
Nov-12-24 04:05PM	OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights (Business Wire) -9.35%
08:00AM	Loading…
Oct-30-24 08:00AM	OmniAb to Participate in Two Investor Conferences in November (Business Wire)
Oct-22-24 08:00AM	OmniAb to Report Third Quarter 2024 Financial Results on November 12 (Business Wire)
Aug-26-24 08:00AM	OmniAb to Participate in Two Investor Conferences in September (Business Wire)
Aug-08-24 04:05PM	OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights (Business Wire) +5.67%
Jul-25-24 08:00AM	OmniAb to Report Second Quarter 2024 Financial Results on August 8 (Business Wire)
Jun-03-24 04:05PM	OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology (Business Wire)
May-20-24 08:05AM	OmniAb to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-15-24 04:05PM	OmniAb Presents High-Throughput Single B-cell Screening xPloration Data at the 20th Annual PEGS Boston Summit (Business Wire)
May-12-24 03:24PM	5 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-09-24 08:56PM	OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM	Loading…
04:05PM	OmniAb Reports First Quarter 2024 Financial Results and Business Highlights (Business Wire)
May-01-24 08:00AM	OmniAb to Participate in Five Investor Conferences in May (Business Wire)
Apr-22-24 08:00AM	OmniAb to Report First Quarter 2024 Financial Results on May 9 (Business Wire)
Mar-21-24 11:31AM	OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.17%
Mar-20-24 08:54PM	OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights (Business Wire)
Feb-28-24 08:27AM	OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock? (Zacks)
Feb-26-24 08:00AM	OmniAb to Report Fourth Quarter 2023 Financial Results on March 20 (Business Wire)
Feb-20-24 08:00AM	OmniAb to Participate in Two Investor Conferences in March (Business Wire)
Dec-14-23 04:30PM	OmniAb Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering & Therapeutics Conference (Business Wire)
Nov-20-23 12:39PM	OmniAb, Inc. (NASDAQ:OABI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 05:03AM	Insider Buying: OmniAb Inc CEO Matthew Foehr Acquires 95,000 Shares (GuruFocus.com) +6.32%
Nov-09-23 05:55PM	OmniAb Highlights OmnidAb Launch and its Expanding Drug Discovery Platform at Todays Research & Technology Virtual Event (Business Wire)
09:24AM	OmniAb Inc (OABI) Reports Decline in Q3 Revenue and Widening Net Loss (GuruFocus.com)
08:00AM	OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights (Business Wire)
08:00AM	Loading…
Nov-02-23 08:00AM	OmniAb to Participate in Two Investor Conferences in November (Business Wire)
Nov-01-23 09:00AM	OmniAb Appoints Steve Love to its Board of Directors (Business Wire)
Oct-31-23 04:28PM	OmniAb Announces Agenda for its Research & Technology Virtual Event (Business Wire)
Oct-26-23 02:32PM	7 of the Best Cheap Stocks to Buy Under $5 in October 2023 (InvestorPlace)
Oct-12-23 08:00AM	OmniAb to Hold Research & Technology Virtual Event on November 9 (Business Wire)
Sep-05-23 08:00AM	OmniAb to Participate in Two Investor Conferences in September (Business Wire)
Aug-15-23 05:20AM	OmniAb, Inc. (NASDAQ:OABI) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 08:06AM	OmniAb, Inc. (NASDAQ:OABI) Analysts Are Cutting Their Estimates: Here's What You Need To Know (Simply Wall St.)
Aug-10-23 04:05PM	OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights (Business Wire) -5.54%
Aug-07-23 04:05PM	OmniAb Announces the Passing of Director Sunil Patel (Business Wire)
Jul-31-23 08:00AM	OmniAb to Report Second Quarter 2023 Financial Results on August 10 (Business Wire)
Jul-17-23 07:35AM	With 60% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns (Simply Wall St.)
Jun-13-23 06:00AM	7 Stocks to Buy for 200% Returns This Year (InvestorPlace) +6.32%
May-18-23 05:09PM	7 Stocks to Buy for Their Massive Upside Potential (InvestorPlace)
May-17-23 04:05PM	OmniAb Launches OmniDeep at the PEGS Boston Conference and Expo (Business Wire)
May-16-23 06:06AM	President of OmniAb Matthew Foehr Buys 22% More Shares \ (Simply Wall St.) +9.12%
May-14-23 08:03AM	OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
May-11-23 10:55PM	Q1 2023 OmniAb Inc Earnings Call (Thomson Reuters StreetEvents) +8.36%
07:00AM	OmniAb Reports First Quarter 2023 Financial Results and Business Highlights (Business Wire)
May-05-23 07:14AM	OmniAb, Inc.'s (NASDAQ:OABI) Share Price Matching Investor Opinion (Simply Wall St.)
May-04-23 06:26AM	10 Best Small-Cap Growth Stocks to Buy Now (Insider Monkey)
May-01-23 08:00AM	OmniAb to Report First Quarter 2023 Financial Results on May 11 (Business Wire)
Apr-26-23 08:01PM	7 Biotech Stocks With Huge Return Potential for Long-Term Investors (InvestorPlace)
Apr-25-23 08:00AM	OmniAb to Participate in Upcoming Investor Conferences in May (Business Wire)
Apr-19-23 08:30AM	Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today (Zacks)
Apr-07-23 10:24PM	OmniAb, Inc. (NASDAQ:OABI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-05-23 06:09AM	OmniAb Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Apr-02-23 08:51AM	Insiders of OmniAb, Inc. (NASDAQ:OABI) are up 11% on their US$2.3m purchase after OmniAb, Inc. (NASDAQ:OABI) rose 14% last week (Simply Wall St.)
Mar-31-23 08:40AM	Do Options Traders Know Something About OmniAb (OABI) Stock We Don't? (Zacks)
Mar-30-23 04:05PM	OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights (Business Wire)
Mar-15-23 11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-09-23 08:00AM	OmniAb to Report Fourth Quarter 2022 Financial Results on March 30 (Business Wire) -5.03%
Mar-08-23 09:53AM	These 2 Strong Buy Penny Stocks Are Poised for a Massive Rally, Say Analysts (TipRanks)
Feb-23-23 07:49AM	Ligand's (LGND) Q4 Sales & Earnings Top, View Raised, Stock Up (Zacks)
Feb-07-23 08:00AM	OmniAb to Participate in Three Upcoming Investor Conferences (Business Wire)
Feb-01-23 06:56AM	With 44% stake, OmniAb, Inc. (NASDAQ:OABI) seems to have captured institutional investors' interest (Simply Wall St.)
Dec-16-22 12:39PM	Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says (Benzinga)
Dec-01-22 08:47AM	Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies (HSB-1940) against PD-1, by combining Quatramers with OmniAbs Picobodies, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets (GlobeNewswire) -5.37%
Nov-15-22 07:00AM	OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights (Business Wire) -10.00%
Nov-03-22 08:00AM	OmniAb to Participate in Two Upcoming Investor Conferences (Business Wire)
Nov-02-22 07:00AM	OmniAb, Inc. to Ring Nasdaq Stock Market Opening Bell (Business Wire) -60.65%
Nov-01-22 04:01PM	OmniAb Announces Completion of Spin-Off and Business Combination (Business Wire) -9.26%
04:01PM	Ligand Announces Completion of OmniAb Spin-Off (Business Wire)

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIGGINS JOHN L	Director	Mar 21 '25	Buy	2.28	4,000	9,120	2,766,887	Mar 21 07:58 PM
HIGGINS JOHN L	Director	Mar 20 '25	Buy	2.35	125,750	295,512	2,762,887	Mar 20 08:15 PM
GUSTAFSON KURT A	Executive VP, Finance and CFO	Feb 16 '25	Option Exercise	0.00	13,541	0	213,466	Feb 19 08:51 PM
GUSTAFSON KURT A	Executive VP, Finance and CFO	Feb 19 '25	Sale	3.67	7,255	26,626	206,211	Feb 19 08:51 PM
FOEHR MATTHEW W	President and CEO	Feb 19 '25	Sale	3.67	19,522	71,646	3,779,160	Feb 19 08:51 PM
FOEHR MATTHEW W	President and CEO	Feb 18 '25	Sale	3.68	13,964	51,388	3,798,682	Feb 19 08:51 PM
Berkman Charles S	Chief Legal Officer	Feb 18 '25	Sale	3.68	8,215	30,231	364,131	Feb 19 08:50 PM
Berkman Charles S	Chief Legal Officer	Feb 19 '25	Sale	3.67	7,255	26,626	356,876	Feb 19 08:50 PM
GUSTAFSON KURT A	Officer	Feb 19 '25	Proposed Sale	3.68	5,188	19,092		Feb 18 08:36 PM
FOEHR MATTHEW W	Officer	Feb 18 '25	Proposed Sale	3.68	13,964	51,390		Feb 18 08:30 PM
Berkman Charles S	Officer	Feb 18 '25	Proposed Sale	3.68	8,215	30,232		Feb 18 08:28 PM
Berkman Charles S	Chief Legal Officer	Jan 21 '25	Sale	3.24	25,489	82,584	343,190	Jan 22 05:41 PM
GUSTAFSON KURT A	Executive VP, Finance and CFO	Jan 21 '25	Sale	3.24	15,526	50,304	212,720	Jan 22 05:40 PM
FOEHR MATTHEW W	President and CEO	Jan 21 '25	Sale	3.24	41,811	135,468	3,749,639	Jan 22 05:40 PM
FOEHR MATTHEW W	Officer	Jan 21 '25	Proposed Sale	3.24	41,811	135,378		Jan 21 07:25 PM
Berkman Charles S	Officer	Jan 21 '25	Proposed Sale	3.24	25,489	82,529		Jan 21 07:24 PM
GUSTAFSON KURT A	Officer	Jan 21 '25	Proposed Sale	3.24	15,526	50,271		Jan 21 07:22 PM
Berkman Charles S	Chief Legal Officer	Dec 09 '24	Sale	4.13	8,022	33,131	323,385	Dec 10 04:47 PM
FOEHR MATTHEW W	President and CEO	Dec 09 '24	Sale	4.13	13,634	56,308	3,714,447	Dec 10 04:44 PM
GUSTAFSON KURT A	Executive VP, Finance and CFO	Dec 09 '24	Sale	4.13	23,871	98,587	200,661	Dec 10 04:41 PM
GUSTAFSON KURT A	Officer	Dec 09 '24	Proposed Sale	4.13	23,871	98,476		Dec 09 08:49 PM
FOEHR MATTHEW W	Officer	Dec 09 '24	Proposed Sale	4.13	13,634	56,245		Dec 09 08:45 PM
Berkman Charles S	Officer	Dec 09 '24	Proposed Sale	4.13	8,022	33,094		Dec 09 08:41 PM
FOEHR MATTHEW W	President and CEO	Nov 25 '24	Option Exercise	3.73	99,434	370,702	3,698,600	Nov 26 04:41 PM
Avista Capital Managing Member	10% Owner	Jun 29 '24	Option Exercise	3.35	66,668	223,338	15,992,372	Jul 02 05:00 PM
FOEHR MATTHEW W	President and CEO	Jun 27 '24	Option Exercise	3.73	59,659	222,416	3,599,166	Jun 27 04:55 PM
FOEHR MATTHEW W	President and CEO	May 24 '24	Buy	4.42	240,000	1,059,840	3,536,665	May 28 05:55 PM
GUSTAFSON KURT A	Executive VP, Finance and CFO	Apr 08 '24	Sale	5.27	6,954	36,648	176,697	Apr 09 06:38 PM
Berkman Charles S	Chief Legal Officer	Apr 08 '24	Sale	5.27	6,954	36,648	292,617	Apr 09 06:37 PM
GUSTAFSON KURT A	Executive VP, Finance & CFO	Apr 01 '24	Sale	5.46	11,849	64,696	170,110	Apr 02 06:30 PM

Open in Screener

TECH

Bio-Techne Corp

Mar 28 • 04:00PM ET

58.73

Dollar change -1.22
Percentage change -2.04	%

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN A BIO QGEN NEO MTD

| Held by: VTI VOO VB RSP VBK IVV SPY XLV IBB IWR

Index	S&P 500	P/E	59.69	EPS (ttm)	0.98	Insider Own	1.12%	Shs Outstand	157.92M	Perf Week	-3.10%
Market Cap	9.28B	Forward P/E	26.69	EPS next Y	2.20	Insider Trans	-0.85%	Shs Float	156.31M	Perf Month	-4.08%
Income	158.11M	PEG	4.57	EPS next Q	0.51	Inst Own	100.12%	Short Float	4.01%	Perf Quarter	-19.58%
Sales	1.20B	P/S	7.76	EPS this Y	7.22%	Inst Trans	1.36%	Short Ratio	4.05	Perf Half Y	-21.64%
Book/sh	13.16	P/B	4.46	EPS next Y	15.95%	ROA	5.85%	Short Interest	6.27M	Perf Year	-14.14%
Cash/sh	1.12	P/C	52.29	EPS next 5Y	13.07%	ROE	7.82%	52W Range	56.60 - 85.57	Perf YTD	-18.46%
Dividend Est.	0.26 (0.43%)	P/FCF	36.51	EPS past 5Y	11.13%	ROI	6.43%	52W High	-31.37%	Beta	1.45
Dividend TTM	0.32 (0.54%)	Quick Ratio	2.77	Sales past 5Y	10.61%	Gross Margin	66.44%	52W Low	3.76%	ATR (14)	2.26
Dividend Ex-Date	Feb 14, 2025	Current Ratio	3.94	EPS Y/Y TTM	-29.62%	Oper. Margin	21.42%	RSI (14)	36.56	Volatility	2.93% 3.80%
Employees	3100	Debt/Eq	0.19	Sales Y/Y TTM	4.46%	Profit Margin	13.22%	Recom	1.78	Target Price	84.08
Option/Short	Yes / Yes	LT Debt/Eq	0.18	EPS Q/Q	26.57%	Payout	30.61%	Rel Volume	0.97	Prev Close	59.95
Sales Surprise	3.94%	EPS Surprise	8.75%	Sales Q/Q	8.96%	Earnings	Feb 05 BMO	Avg Volume	1.55M	Price	58.73
SMA20	-3.82%	SMA50	-12.04%	SMA200	-18.90%	Trades		Volume	1,505,058	Change	-2.04%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight

Show Previous Ratings

Mar-28-25 05:06AM	Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch (StockStory)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
07:00AM	Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany (PR Newswire)
Mar-24-25 07:00AM	Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting (PR Newswire)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
05:03AM	Loading…
Mar-12-25 05:03AM	Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
05:01AM	Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) (StockStory)
Mar-10-25 07:00AM	Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System (PR Newswire)
Mar-07-25 11:31AM	Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-05-25 04:02AM	Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
Mar-04-25 04:02AM	Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks (StockStory)
Mar-03-25 07:00AM	Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes (PR Newswire)
04:03AM	Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
Feb-28-25 08:36AM	Weitz Partners III Opportunity Fund Added Bio-Techne Corporation (TECH) to its Portfolio (Insider Monkey)
Feb-27-25 07:00AM	Bio-Techne to Present at Investor Conferences (PR Newswire)
07:00AM	Loading…
Feb-20-25 07:00AM	Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology (PR Newswire)
Feb-18-25 07:00AM	Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System (PR Newswire)
Feb-10-25 07:19PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Feb-06-25 02:09AM	Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:40AM	Q2 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-05-25 08:18PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
08:13AM	Illumina (ILMN) Reports Earnings Tomorrow: What To Expect (StockStory)
06:41AM	Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars (StockStory)
06:30AM	Bio-Techne Releases Second Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Feb-04-25 07:00AM	Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors (PR Newswire)
Jan-21-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to BrainChild Bio (PR Newswire)
07:00AM	Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results (PR Newswire)
Jan-10-25 07:00AM	Bio-Techne Expands RandD Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
07:00AM	Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
07:00AM	Loading…
Jan-08-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Seattle Children's Therapeutics (PR Newswire)
07:00AM	BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025 (PR Newswire)
Jan-07-25 07:00AM	BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC (PR Newswire)
Dec-20-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-19-24 07:00AM	BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT (PR Newswire)
Dec-18-24 07:00AM	ScaleReady awards a G-Rex Grant to Moonlight Bio (PR Newswire) -5.13%
Dec-12-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY (PR Newswire)
Dec-10-24 07:00AM	BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY (PR Newswire)
Dec-09-24 07:33PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Nov-29-24 11:32AM	Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-24 07:00AM	BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-25-24 09:02AM	Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne (PR Newswire)
Nov-22-24 09:00AM	OverT Bio Receives $120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements (Business Wire)
Nov-20-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES (PR Newswire)
Nov-18-24 07:00AM	BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH (PR Newswire)
Nov-15-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -6.85%
Nov-14-24 07:00AM	BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO (PR Newswire)
Nov-11-24 05:47PM	UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
07:00AM	BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
Nov-08-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES (PR Newswire)
Nov-07-24 07:00AM	ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy (PR Newswire)
Nov-06-24 07:00AM	BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING (PR Newswire)
12:05AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Nov-05-24 06:51PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	LUNAPHORE COMET PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH (PR Newswire)
Oct-31-24 10:39AM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
03:08AM	Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... (GuruFocus.com)
01:01AM	Q1 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 06:30AM	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS (PR Newswire) +7.46%
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Oct-29-24 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Luminary Therapeutics (PR Newswire)
Oct-17-24 06:57PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Oct-10-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS (PR Newswire)
Oct-09-24 08:00AM	Bio-Techne Announces 'The Simple Way to Advance Protein Research' Virtual Event Series (PR Newswire)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to LIfT Biosciences (PR Newswire)
Oct-08-24 04:25PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (PR Newswire)
Oct-07-24 07:00AM	ScaleReady announces a G-Rex Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff (PR Newswire)
Oct-03-24 05:34PM	S&P 500 Gains and Losses Today: Oil Stocks Rise as Global Tensions Escalate (Investopedia)
Sep-26-24 07:00AM	LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH (PR Newswire)
Sep-24-24 07:00AM	BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING (PR Newswire)
Sep-19-24 06:37PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) +5.03%
Sep-18-24 07:00AM	ScaleReady announces a G-Rex Grant has been awarded to ImmunoScape (PR Newswire)
07:00AM	BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT (PR Newswire)
Sep-17-24 07:00AM	Verismo Therapeutics Awarded a ScaleReady G-Rex Grant (PR Newswire)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to Verismo Therapeutics (PR Newswire)
Sep-16-24 07:00AM	ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex Manufacture of CAR-T and TCR Therapies (PR Newswire)
Sep-09-24 05:11AM	Heres What Dragged Bio-Techne Corporation (TECH)? (Insider Monkey)
Aug-27-24 07:00AM	ScaleReady announces the inaugural G-Rex Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine (PR Newswire)
Aug-26-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Aug-23-24 01:04AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Aug-08-24 02:28PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-07-24 07:20PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -9.51%
06:30AM	BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jul-31-24 07:00AM	BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM (PR Newswire)
Jul-29-24 07:00AM	BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO (PR Newswire)
Jul-15-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jul-12-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace)
Jul-02-24 07:06PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
May-31-24 07:00AM	BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES (PR Newswire)
May-30-24 07:00AM	BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE (PR Newswire)
May-29-24 07:00AM	ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing (PR Newswire)
May-23-24 10:26AM	Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 (Insider Monkey)
07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE (PR Newswire)
May-22-24 07:00AM	BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY (PR Newswire)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-14-24 04:49AM	Bio-Techne Corporation (TECH) Declined on Weak Q4 Results (Insider Monkey)
May-08-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 (PR Newswire)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herr Amy E.	Director	Feb 14 '25	Option Exercise	44.33	1,976	87,596	3,836	Feb 18 04:49 PM
Herr Amy E.	Director	Feb 14 '25	Sale	65.96	1,860	122,691	1,976	Feb 18 04:49 PM
JOSHUA MOLHO	Domestic Partner of Director	Feb 14 '25	Proposed Sale	65.96	1,860	122,691		Feb 14 04:08 PM
McManus Matthew	President - DGS	Feb 01 '25	Option Exercise	0.00	4,620	0	4,620	Feb 04 05:31 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Feb 01 '25	Option Exercise	0.00	3,320	0	14,401	Feb 04 05:27 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Option Exercise	37.70	13,392	504,878	52,396	Jan 29 04:35 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Sale	77.29	13,392	1,035,013	39,004	Jan 29 04:35 PM
KIM KELDERMAN	Director	Jan 27 '25	Proposed Sale	77.05	13,392	1,031,854		Jan 27 04:24 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 01 '24	Option Exercise	0.00	9,912	0	14,351	Nov 05 04:48 PM
Hippel James	CFO	Nov 01 '24	Option Exercise	0.00	13,159	0	113,085	Nov 05 04:46 PM
HIGGINS JOHN L	Director	Sep 12 '24	Option Exercise	22.95	6,000	137,700	48,608	Sep 16 04:18 PM
Kelderman Kim	Chief Executive Officer	Aug 29 '24	Option Exercise	66.97	1,492	99,919	41,434	Sep 03 04:05 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '24	Option Exercise	0.00	49	0	1,696	Aug 19 05:28 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Option Exercise	22.95	16,000	367,200	59,401	Aug 12 04:08 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Sale	72.10	16,000	1,153,664	43,401	Aug 12 04:08 PM
ROBERT V. BAUMGARTNER	Director	Aug 08 '24	Proposed Sale	72.10	16,000	1,153,664		Aug 08 04:13 PM
Hippel James	CFO	Aug 02 '24	Option Exercise	31.26	53,000	1,656,780	136,002	Aug 06 04:23 PM
Kelderman Kim	Chief Executive Officer	Jul 31 '24	Option Exercise	37.70	14,000	527,800	49,421	Aug 02 04:17 PM
Hippel James	CFO	Jul 23 '24	Option Exercise	31.26	35,000	1,094,100	107,284	Jul 25 04:31 PM
HIGGINS JOHN L	Director	Jul 08 '24	Option Exercise	22.95	6,000	137,700	42,608	Jul 10 04:35 PM
HIGGINS JOHN L	Director	May 14 '24	Option Exercise	22.95	4,000	91,800	40,608	May 16 04:17 PM
HIGGINS JOHN L	Director	May 14 '24	Sale	83.84	4,000	335,377	36,608	May 16 04:17 PM

OABI

OmniAb Inc

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience